Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell lines.
暂无分享,去创建一个
C Decaestecker | I Salmon | I Camby | P Van Ham | J L Pasteels | R Kiss | R. Kiss | C. Decaestecker | J. Brotchi | I. Salmon | J. Pasteels | P. Van Ham | C. De Hauwer | F. Darro | I. Camby | A Danguy | I. Migeotte | I Migeotte | J Brotchi | A. Danguy | F Darro | C De Hauwer | C Verbeek | C. Verbeek
[1] Á. Hernanz,et al. Modulation of murine peritoneal macrophage functions by gastrin , 1996, Peptides.
[2] K. Fukuyama,et al. Transfection of an Invasive Human Astrocytoma Cell Line with a TIMP‐1 cDNA: Modulation of Astrocytoma Invasive Potential , 1996, Journal of neuropathology and experimental neurology.
[3] L. Matrisian,et al. Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.
[4] A. Yu,et al. Tumor Necrosis Factor‐α and Basic Fibroblast Growth Factor Decrease Glial Fibrillary Acidic Protein and Its Encoding mRNA in Astrocyte Cultures and Glioblastoma Cells , 1995, Journal of neurochemistry.
[5] M. Pierre,et al. Rapid TGFβ1 effects on actin cytoskeleton of astrocytes: Comparison with other factors and implications for cell motility , 1995, Glia.
[6] Pomila Singh,et al. Novel Gastrin Receptors Mediate Mitogenic Effects of Gastrin and Processing Intermediates of Gastrin on Swiss 3T3 Fibroblasts , 1995, The Journal of Biological Chemistry.
[7] J. Rehfeld. Progastrin and its products in the cerebellum , 1991, Neuropeptides.
[8] R. Kiss,et al. The characterization of nuclear-DNA content, the proliferative activity and the immunohistochemical expression of gfap, vim, leu-7, s-100, p53 and cathepsin-d in human glioblastoma multiformes (hgbms) versus human gbm cell-lines grafted into the brains of nude-mice. , 1995, International journal of oncology.
[9] S. Vandenberg. Current Diagnostic Concepts of Astrocytic Tumors , 1992, Journal of neuropathology and experimental neurology.
[10] J. Rehfeld,et al. Expression but incomplete maturation of progastrin in colorectal carcinomas. , 1993, Gastroenterology.
[11] R. Kiss,et al. Relationship between DNA ploidy level and tumor sociology behavior in 12 nervous cell lines. , 1995, Cytometry.
[12] M. Berens,et al. Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. , 1996, Journal of cell science.
[13] T. Sasaki,et al. Cholecystokinin-B/gastrin receptors mediate rapid formation of actin stress fibers. , 1996, Oncogene.
[14] C Decaestecker,et al. Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables. , 1997, Journal of neurosurgery.
[15] Erkki Ruoslahti,et al. Stretching Is Good for a Cell , 1997, Science.
[16] Á. Hernanz,et al. Effect of cholecystokinin and gastrin on human peripheral blood lymphocyte functions, implication of cyclic AMP and interleukin 2 , 1997, Regulatory Peptides.
[17] S. Coons,et al. Dichotomy of astrocytoma migration and proliferation , 1996, International journal of cancer.
[18] K. von der Mark,et al. Specific Induction of Cell Motility on Laminin by 7 Integrin (*) , 1996, The Journal of Biological Chemistry.
[19] J. D. De Mey,et al. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[20] C Decaestecker,et al. Dynamic characterization of glioblastoma cell motility. , 1997, Biochemical and biophysical research communications.
[21] R. Miskin,et al. Components of the Plasminogen Activator System in Astrocytes Are Modulated by Tumor Necrosis Factor‐α and Interleukin‐1β Through Similar Signal Transduction Pathways , 1995 .
[22] Richard O. Hynes,et al. Integrins: A family of cell surface receptors , 1987, Cell.
[23] R. Fox,et al. A novel gastrin-binding protein in the human eosinophil. , 1998, Biochemical and biophysical research communications.
[24] G. Pilkington. Tumour Cell Migration in the Central Nervous System , 1994, Brain pathology.
[25] J. Rehfeld,et al. Gastrin/CCK-like immunoreactivity in the nervous system of coelenterates , 2004, Histochemistry.
[26] T. Seufferlein,et al. The human CCKB/gastrin receptor transfected into rat1 fibroblasts mediates activation of MAP kinase, p74raf-1 kinase, and mitogenesis. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[27] D. Silbergeld,et al. Assessment of brain tumor cell motility in vivo and in vitro. , 1995, Journal of neurosurgery.
[28] C. S. Chen,et al. Geometric control of cell life and death. , 1997, Science.
[29] B. Scheithauer,et al. Histopathology, classification, and grading of gliomas , 1995, Glia.
[30] A. M. Romanic,et al. Extracellular Matrix‐Degrading Proteinases in the Nervous System , 1994, Brain pathology.
[31] B. Radotra,et al. GLIOMA INVASION IN VITRO IS MEDIATED BY CD44–HYALURONAN INTERACTIONS , 1997, The Journal of pathology.
[32] T. Hökfelt,et al. Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues , 1991, Neuropeptides.
[33] J. Holst,et al. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK , 1980, Nature.
[34] C. Seva,et al. Growth-promoting effects of glycine-extended progastrin. , 1994, Science.
[35] R. Jensen,et al. Cholecystokinin-stimulated tyrosine phosphorylation of p125FAK and paxillin is mediated by phospholipase C-dependent and -independent mechanisms and requires the integrity of the actin cytoskeleton and participation of p21rho. , 1997, The Biochemical journal.
[36] J. Rehfeld,et al. Ovarian cancers express and process progastrin. , 1993, Cancer research.
[37] T. Yamada,et al. Biological activity of progastrin posttranslational processing intermediates. , 1987, The American journal of physiology.
[38] J. Rehfeld,et al. Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways. , 1986, The Journal of biological chemistry.
[39] G. Baldwin. Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Rehfeld,et al. The tumor biology of gastrin and cholecystokinin. , 1994, Advances in cancer research.
[41] C Decaestecker,et al. Improving Morphology‐Based Malignancy Grading Schemes in Astrocytic Tumors by Means of Computer‐Assisted Techniques , 1998, Brain pathology.
[42] Á. Hernanz,et al. Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide , 1995, Regulatory Peptides.
[43] R. Kiss,et al. Identification of High Versus Lower Risk Clinical Subgroups in a Group of Adult Patients with Supratentorial Anaplastic Astrocytomas , 1995, Journal of neuropathology and experimental neurology.
[44] N. Tawil,et al. Integrins in point contacts mediate cell spreading: factors that regulate integrin accumulation in point contacts vs. focal contacts , 1993, The Journal of cell biology.
[45] R. Peter,et al. CCK/gastrin-like immunoreactivity in brain and gut, and CCK suppression of feeding in goldfish. , 1994, The American journal of physiology.
[46] R. Kiss,et al. Influence of gastrin on human astrocytic tumor cell proliferation. , 1996, Journal of the National Cancer Institute.
[47] J C Reubi,et al. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. , 1997, Cancer research.
[48] J. Rehfeld,et al. Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity , 1978, Brain Research.
[49] Á. Hernanz,et al. Inhibition of Human Neutrophil Functions by Sulfated and Nonsulfated Cholecystokinin Octapeptides , 1997, Peptides.
[50] K. Schlingensiepen,et al. Effects of Transforming Growth Factor‐β1 on Collagen Synthesis, Integrin Expression, Adhesion an Invasion of Glioma Cells , 1995 .
[51] R. Bold,et al. Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B. , 1994, Biochemical and biophysical research communications.
[52] M. De la Fuente,et al. Modulation of human neutrophil function in vitro by gastrin. , 1997, The Journal of endocrinology.
[53] G. Barnett,et al. Effect of recombinant tumor necrosis factor-alpha on three-dimensional growth, morphology, and invasiveness of human glioblastoma cells in vitro. , 1993, Journal of neurosurgery.
[54] R. Kiss,et al. The influence of gastrin and/or cholecystokinin antagonists on the proliferation of three human astrocytic tumor cell lines , 1996, Neuropeptides.
[55] J. Bruner,et al. Immunohistochemical Localization of Plasminogen Activator Inhibitor Type 1 in Human Brain Tumors , 1994, Journal of neuropathology and experimental neurology.
[56] L. Hilsted. Glycine-extended gastrin precursors , 1991, Regulatory Peptides.